Refractory Childhood Fibrolamellar Carcinoma
specificChildhood fibrolamellar carcinoma that is resistant to treatment.
8
Centers
8
Active Trials
—
Cancer Funding
Top Centers for Refractory Childhood Fibrolamellar Carcinoma(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 56.2 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 56.2 |
| 3 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 56.2 |
| 4 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 56.2 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.2 |
| 6 | University of Illinois Cancer CenterChicago, IL Active Research Program | 56.2 |
| 7 | Boston University Cancer CenterBoston, MA Active Research Program | 56.2 |
| 8 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 56.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →